-
Story
Compassionate use: Providing access to much needed treatments -
Press Release
Novartis pledges 10-year commitment with Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and other leading organizations to co-create effective, measurable solutions for health equity
-
Press Release
Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19
-
Press Release
Novartis Resolves Legacy FCPA Investigations
-
Press Release
Novartis resolves legacy litigation matters, finalizing settlement of speaker program litigation with Government in the US and positioning company for the future by fully scaling its next-generation digital engagement technologies
-
Press Release
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
-
Press Release
Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
-
Story
In your neighborhood: a community-based approach to health equity in the US -
Story
Doing the right thing is good business -
Story
Positive gains are needed to accelerate change for women with lung disease -
Story
Sleuths use hi-tech sensors to fight pharmaceutical crime -
Story
Women in Science: Jean Silveri